GERMANY UP CLOSE: A Balancing Act But Medtech Is Upbeat Going Into 2016
This article was originally published in Clinica
Executive Summary
The German medtech industry is in the midst of the heaviest period of national healthcare legislation for two decades, and in the home market, at least, the demands of manufacturers are being heard. But there remain improvements to strive for in Germany and at EU regulatory level, says BVMed’s communications head Manfred Beeres, who spoke to Clinica at Medica 2015